KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $54.8 million.

  • Nektar Therapeutics' Change in Acquisitions & Divestments fell 1590.09% to $54.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $257.8 million, marking a year-over-year decrease of 4028.77%. This contributed to the annual value of $340.4 million for FY2024, which is 4770.78% down from last year.
  • Per Nektar Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $54.8 million for Q3 2025, which was down 1590.09% from $68.6 million recorded in Q2 2025.
  • Nektar Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $308.8 million for Q2 2021, and its period low was $54.8 million during Q3 2025.
  • Over the past 5 years, Nektar Therapeutics' median Change in Acquisitions & Divestments value was $160.0 million (recorded in 2022), while the average stood at $167.2 million.
  • In the last 5 years, Nektar Therapeutics' Change in Acquisitions & Divestments skyrocketed by 64054.44% in 2021 and then tumbled by 6345.42% in 2024.
  • Over the past 5 years, Nektar Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $264.3 million in 2021, then decreased by 24.39% to $199.8 million in 2022, then decreased by 21.67% to $156.5 million in 2023, then crashed by 58.39% to $65.1 million in 2024, then dropped by 15.84% to $54.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $54.8 million in Q3 2025, compared to $68.6 million in Q2 2025 and $69.3 million in Q1 2025.